| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |